Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties

Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties

Background: During myocardial infarction (MI), billions of cardiomyocytes are lost. The optimal therapy should effectively replace damaged cardiomyocytes, possibly with stem cells able to engraft and differentiate into adult functional cardiomyocytes. As such, cardiac atrial appendage stem cells (CA...

Full description

Bibliographic Details
Main Authors: Lize Evens, Ellen Heeren, Jean-Luc Rummens, Annelies Bronckaers, Marc Hendrikx, Dorien Deluyker, Virginie Bito
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
stem cells
aldehyde dehydrogenase
CASCs
glycated proteins
advanced glycation end products
proliferation
Online Access:https://www.mdpi.com/2077-0383/10/13/2964

Internet

https://www.mdpi.com/2077-0383/10/13/2964

Similar Items